However, another study has provided evidence of a bimodal pattern of the Notch pathway in HNSCC, where a small subset of patients harbour Notch inactivating mutations (10–15%) but interestingly, a larger subset (32%) have Notch 1 pathway overexpression and downstream pathway activation [44]. This evidence concerns the gene NOTCH1 and head and neck squamous cell carcinoma.